Figure 5 | British Journal of Cancer

Figure 5

From: Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01

Figure 5

Reduction of Bcl2, BclXL, cIAP1 levels without alteration of the expression of Bak or Bax in TE12 or H460 cells treated with VA (1.0 or 5.0 mM) and UCN-01 (500 nM) concurrent combinations. Representative data of two independent experiments with similar results are shown here.

Back to article page